0 XP   0   0   0

Epigenomics AG










Financial Health of Epigenomics AG




Comparing to competitors in the Other industry




  Industry Rankings  


Epigenomics AG
Buy, Hold or Sell?

Should you buy, hold or sell Epigenomics AG?

I guess you are interested in Epigenomics AG. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Epigenomics AG

Let's start. I'm going to help you getting a better view of Epigenomics AG. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Epigenomics AG even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Epigenomics AG is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Epigenomics AG. The closing price on 2022-12-02 was €0.358 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Epigenomics AG Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Epigenomics AG.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Epigenomics AG earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Epigenomics AG to the Other industry mean.
  • A Net Profit Margin of -1,075.9% means that €-10.76 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Epigenomics AG:

  • The MRQ is -1,075.9%. The company is making a huge loss. -2
  • The TTM is -1,344.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,075.9%TTM-1,344.6%+268.8%
TTM-1,344.6%YOY-982.3%-362.3%
TTM-1,344.6%5Y-1,474.5%+129.9%
5Y-1,474.5%10Y-1,474.5%0.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,075.9%8.2%-1,084.1%
TTM-1,344.6%7.4%-1,352.0%
YOY-982.3%7.3%-989.6%
5Y-1,474.5%6.7%-1,481.2%
10Y-1,474.5%6.6%-1,481.1%
1.1.2. Return on Assets

Shows how efficient Epigenomics AG is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Epigenomics AG to the Other industry mean.
  • -8.2% Return on Assets means that Epigenomics AG generated €-0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Epigenomics AG:

  • The MRQ is -8.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.2%TTM-8.4%+0.1%
TTM-8.4%YOY-16.0%+7.7%
TTM-8.4%5Y-19.7%+11.4%
5Y-19.7%10Y-19.7%0.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.2%1.0%-9.2%
TTM-8.4%1.0%-9.4%
YOY-16.0%0.9%-16.9%
5Y-19.7%0.9%-20.6%
10Y-19.7%0.9%-20.6%
1.1.3. Return on Equity

Shows how efficient Epigenomics AG is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Epigenomics AG to the Other industry mean.
  • -11.2% Return on Equity means Epigenomics AG generated €-0.11 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Epigenomics AG:

  • The MRQ is -11.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -10.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.2%TTM-10.2%-1.0%
TTM-10.2%YOY-27.5%+17.3%
TTM-10.2%5Y-30.2%+20.0%
5Y-30.2%10Y-30.2%0.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.2%3.1%-14.3%
TTM-10.2%2.9%-13.1%
YOY-27.5%2.6%-30.1%
5Y-30.2%2.4%-32.6%
10Y-30.2%2.4%-32.6%

1.2. Operating Efficiency of Epigenomics AG.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Epigenomics AG is operating .

  • Measures how much profit Epigenomics AG makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Epigenomics AG to the Other industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Epigenomics AG:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-201.7%+201.7%
TTM-5Y-813.8%+813.8%
5Y-813.8%10Y-813.8%0.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.1%-17.1%
TTM-9.1%-9.1%
YOY-201.7%9.2%-210.9%
5Y-813.8%8.5%-822.3%
10Y-813.8%8.5%-822.3%
1.2.2. Operating Ratio

Measures how efficient Epigenomics AG is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Other industry mean).
  • An Operation Ratio of 10.63 means that the operating costs are €10.63 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Epigenomics AG:

  • The MRQ is 10.628. The company is inefficient in keeping operating costs low. -1
  • The TTM is 23.107. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ10.628TTM23.107-12.479
TTM23.107YOY12.540+10.567
TTM23.1075Y18.309+4.798
5Y18.30910Y18.3090.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ10.6281.218+9.410
TTM23.1071.189+21.918
YOY12.5401.203+11.337
5Y18.3091.289+17.020
10Y18.3091.314+16.995

1.3. Liquidity of Epigenomics AG.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Epigenomics AG is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Other industry mean).
  • A Current Ratio of 3.88 means the company has €3.88 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Epigenomics AG:

  • The MRQ is 3.875. The company is very able to pay all its short-term debts. +2
  • The TTM is 7.210. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.875TTM7.210-3.335
TTM7.210YOY4.910+2.300
TTM7.2105Y4.777+2.433
5Y4.77710Y4.7770.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ3.8751.491+2.384
TTM7.2101.465+5.745
YOY4.9101.475+3.435
5Y4.7771.299+3.478
10Y4.7771.286+3.491
1.3.2. Quick Ratio

Measures if Epigenomics AG is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Epigenomics AG to the Other industry mean.
  • A Quick Ratio of 0.03 means the company can pay off €0.03 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Epigenomics AG:

  • The MRQ is 0.029. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.021. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.029TTM0.021+0.008
TTM0.021YOY0.320-0.299
TTM0.0215Y0.231-0.210
5Y0.23110Y0.2310.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0290.612-0.583
TTM0.0210.602-0.581
YOY0.3200.600-0.280
5Y0.2310.563-0.332
10Y0.2310.552-0.321

1.4. Solvency of Epigenomics AG.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Epigenomics AG assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Epigenomics AG to Other industry mean.
  • A Debt to Asset Ratio of 0.27 means that Epigenomics AG assets are financed with 26.6% credit (debt) and the remaining percentage (100% - 26.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Epigenomics AG:

  • The MRQ is 0.266. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.177. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.266TTM0.177+0.088
TTM0.177YOY0.299-0.122
TTM0.1775Y0.278-0.101
5Y0.27810Y0.2780.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2660.562-0.296
TTM0.1770.583-0.406
YOY0.2990.586-0.287
5Y0.2780.583-0.305
10Y0.2780.576-0.298
1.4.2. Debt to Equity Ratio

Measures if Epigenomics AG is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Epigenomics AG to the Other industry mean.
  • A Debt to Equity ratio of 36.2% means that company has €0.36 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Epigenomics AG:

  • The MRQ is 0.362. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.222. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.362TTM0.222+0.139
TTM0.222YOY0.466-0.243
TTM0.2225Y0.429-0.206
5Y0.42910Y0.4290.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3621.244-0.882
TTM0.2221.337-1.115
YOY0.4661.370-0.904
5Y0.4291.439-1.010
10Y0.4291.455-1.026

2. Market Valuation of Epigenomics AG

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Epigenomics AG generates.

  • Above 15 is considered overpriced but always compare Epigenomics AG to the Other industry mean.
  • A PE ratio of -3.58 means the investor is paying €-3.58 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Epigenomics AG:

  • The EOD is -3.754. Company is losing money. -2
  • The MRQ is -3.576. Company is losing money. -2
  • The TTM is -4.593. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-3.754MRQ-3.576-0.178
MRQ-3.576TTM-4.593+1.018
TTM-4.593YOY-4.844+0.250
TTM-4.5935Y-8.259+3.666
5Y-8.25910Y-8.2590.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD-3.75436.308-40.062
MRQ-3.57638.458-42.034
TTM-4.59344.588-49.181
YOY-4.84448.072-52.916
5Y-8.25940.090-48.349
10Y-8.25941.443-49.702
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Epigenomics AG.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Epigenomics AG:

  • The MRQ is 21.536. Seems overpriced? -1
  • The TTM is 7.324. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ21.536TTM7.324+14.212
TTM7.324YOY-126.143+133.467
TTM7.3245Y-41.221+48.545
5Y-41.22110Y-41.2210.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ21.5360.154+21.382
TTM7.3240.050+7.274
YOY-126.1430.186-126.329
5Y-41.2210.158-41.379
10Y-41.2210.155-41.376

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Epigenomics AG is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Other industry mean).
  • A PB ratio of 0.40 means the investor is paying €0.40 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Epigenomics AG:

  • The EOD is 0.420. Very good. +2
  • The MRQ is 0.400. Very good. +2
  • The TTM is 0.443. Very good. +2
Trends
Current periodCompared to+/- 
EOD0.420MRQ0.400+0.020
MRQ0.400TTM0.443-0.043
TTM0.443YOY2.387-1.943
TTM0.4435Y3.667-3.224
5Y3.66710Y3.6670.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD0.4201.411-0.991
MRQ0.4001.419-1.019
TTM0.4431.575-1.132
YOY2.3871.352+1.035
5Y3.6671.288+2.379
10Y3.6671.330+2.337
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Epigenomics AG compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.167-0.299+79%0.282-159%0.071-335%0.071-335%
Book Value Growth---0.259-0.209-19%0.128-302%-0.143-45%-0.143-45%
Book Value Per Share--0.8521.115-24%1.077-21%0.915-7%0.915-7%
Book Value Per Share Growth---0.196-0.250+28%-0.075-62%-0.098-50%-0.098-50%
Current Ratio--3.8757.210-46%4.910-21%4.777-19%4.777-19%
Debt To Asset Ratio--0.2660.177+50%0.299-11%0.278-5%0.278-5%
Debt To Equity Ratio--0.3620.222+63%0.466-22%0.429-16%0.429-16%
Dividend Per Share----0%-0%-0%-0%
Eps---0.095-0.112+18%-0.146+54%-0.256+168%-0.256+168%
Eps Growth---0.166-0.645+289%0.763-122%0.098-270%0.098-270%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin---10.759-13.446+25%-9.823-9%-14.745+37%-14.745+37%
Operating Margin----0%-2.0170%-8.1380%-8.1380%
Operating Ratio--10.62823.107-54%12.540-15%18.309-42%18.309-42%
Pb Ratio0.420+5%0.4000.443-10%2.387-83%3.667-89%3.667-89%
Pe Ratio-3.754-5%-3.576-4.593+28%-4.844+35%-8.259+131%-8.259+131%
Peg Ratio--21.5367.324+194%-126.143+686%-41.221+291%-41.221+291%
Price Per Share0.358+5%0.3410.499-32%1.893-82%6.369-95%6.369-95%
Price To Total Gains Ratio-2.143-5%-2.041-2.069+1%-1.812-11%-1.908-7%-1.908-7%
Profit Growth---12.224-50.077+310%69.749-118%16.977-172%16.977-172%
Quick Ratio--0.0290.021+37%0.320-91%0.231-87%0.231-87%
Return On Assets---0.082-0.084+2%-0.160+95%-0.197+140%-0.197+140%
Return On Equity---0.112-0.102-9%-0.275+146%-0.302+170%-0.302+170%
Revenue Growth--0.085-8.313+9833%-0.182+313%-2.604+3148%-2.604+3148%
Total Gains Per Share---0.167-0.299+79%0.282-159%0.071-335%0.071-335%
Total Gains Per Share Growth---0.114-0.338+196%0.313-137%0.004-3294%0.004-3294%
Usd Book Value--14664482.50018893953.750-22%10771811.250+36%12483983.167+17%12483983.167+17%
Usd Book Value Change Per Share---0.176-0.315+79%0.296-159%0.075-335%0.075-335%
Usd Book Value Per Share--0.8971.174-24%1.134-21%0.963-7%0.963-7%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.100-0.118+18%-0.154+54%-0.269+168%-0.269+168%
Usd Price Per Share0.377+5%0.3590.525-32%1.992-82%6.704-95%6.704-95%
Usd Profit---1641900.000-1908971.875+16%-860155.625-48%-2571818.833+57%-2571818.833+57%
Usd Revenue--152612.500149191.875+2%1663739.375-91%600346.000-75%600346.000-75%
Usd Total Gains Per Share---0.176-0.315+79%0.296-159%0.075-335%0.075-335%
 EOD+2 -3MRQTTM+20 -11YOY+11 -205Y+13 -1810Y+13 -18

3.2. Fundamental Score

Let's check the fundamental score of Epigenomics AG based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.754
Price to Book Ratio (EOD)Between0-10.420
Net Profit Margin (MRQ)Greater than0-10.759
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.029
Current Ratio (MRQ)Greater than13.875
Debt to Asset Ratio (MRQ)Less than10.266
Debt to Equity Ratio (MRQ)Less than10.362
Return on Equity (MRQ)Greater than0.15-0.112
Return on Assets (MRQ)Greater than0.05-0.082
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Epigenomics AG based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.233
Ma 20Greater thanMa 500.335
Ma 50Greater thanMa 1000.329
Ma 100Greater thanMa 2000.370
OpenGreater thanClose0.354
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-09-30. Currency in EUR. All numbers in thousands.

Summary
Total Assets18,970
Total Liabilities5,037
Total Stockholder Equity13,933
 As reported
Total Liabilities 5,037
Total Stockholder Equity+ 13,933
Total Assets = 18,970

Assets

Total Assets18,970
Total Current Assets16,893
Long-term Assets16,893
Total Current Assets
Cash And Cash Equivalents 15,773
Net Receivables 128
Inventory 217
Other Current Assets 775
Total Current Assets  (as reported)16,893
Total Current Assets  (calculated)16,893
+/-0
Long-term Assets
Long-term Assets Other 1
Long-term Assets  (as reported)2,077
Long-term Assets  (calculated)1
+/- 2,076

Liabilities & Shareholders' Equity

Total Current Liabilities4,359
Long-term Liabilities678
Total Stockholder Equity13,933
Total Current Liabilities
Accounts payable 1,121
Other Current Liabilities 872
Total Current Liabilities  (as reported)4,359
Total Current Liabilities  (calculated)1,993
+/- 2,366
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt966
Long-term Liabilities  (as reported)678
Long-term Liabilities  (calculated)966
+/- 288
Total Stockholder Equity
Total Stockholder Equity (as reported)13,933
Total Stockholder Equity (calculated)0
+/- 13,933
Other
Capital Stock16,357
Common Stock Shares Outstanding 16,357
Net Invested Capital 13,933
Net Working Capital 12,534



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
18,657
15,547
12,963
13,989
13,551
11,041
8,830
6,797
9,499
9,690
27,011
24,663
22,438
20,620
18,970
18,97020,62022,43824,66327,0119,6909,4996,7978,83011,04113,55113,98912,96315,54718,657
   > Total Current Assets 
14,185
10,562
7,716
12,123
11,803
9,435
7,364
5,469
8,398
8,662
26,027
23,712
20,811
18,769
16,893
16,89318,76920,81123,71226,0278,6628,3985,4697,3649,43511,80312,1237,71610,56214,185
       Cash And Cash Equivalents 
12,126
8,437
5,501
10,155
10,252
7,722
5,735
3,485
7,446
6,949
23,555
22,963
20,039
18,043
15,773
15,77318,04320,03922,96323,5556,9497,4463,4855,7357,72210,25210,1555,5018,43712,126
       Short-term Investments 
747
700
776
880
731
854
905
961
0
0
0
0
0
0
0
0000000961905854731880776700747
       Net Receivables 
132
326
282
40
73
56
91
205
53
78
1,769
34
57
59
128
1285957341,769785320591567340282326132
       Inventory 
462
422
302
313
291
241
197
122
279
242
273
176
115
77
217
21777115176273242279122197241291313302422462
       Other Current Assets 
718
40
855
112
456
51
436
40
620
28
430
50
600
40
775
775406005043028620404365145611285540718
   > Long-term Assets 
4,472
4,985
5,247
1,866
1,748
1,606
1,466
1,328
1,101
1,028
984
951
1,627
1,851
2,077
2,0771,8511,6279519841,0281,1011,3281,4661,6061,7481,8665,2474,9854,472
       Intangible Assets 
0
0
0
333
288
239
0
145
0
69
0
60
0
89
0
08906006901450239288333000
       Long-term Assets Other 
4,472
4,985
5,247
1,866
1,748
0
0
-1
0
0
0
0
0
0
1
1000000-1001,7481,8665,2474,9854,472
> Total Liabilities 
2,872
3,844
4,038
4,360
7,279
3,724
3,286
2,933
3,020
3,329
2,777
2,543
3,351
3,954
5,037
5,0373,9543,3512,5432,7773,3293,0202,9333,2863,7247,2794,3604,0383,8442,872
   > Total Current Liabilities 
2,226
2,993
3,232
3,619
6,592
3,099
2,723
2,437
2,546
2,877
2,348
2,143
2,582
3,214
4,359
4,3593,2142,5822,1432,3482,8772,5462,4372,7233,0996,5923,6193,2322,9932,226
       Short-term Debt 
0
205
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000002050
       Short Long Term Debt 
0
205
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000002050
       Accounts payable 
986
1,503
1,450
1,430
760
906
557
629
1,158
828
849
503
814
714
1,121
1,1217148145038498281,1586295579067601,4301,4501,503986
       Other Current Liabilities 
769
5
843
6
4,361
4
905
4
745
32
723
0
559
0
872
8720559072332745490544,36168435769
   > Long-term Liabilities 
646
851
806
741
687
625
563
496
474
452
429
400
769
740
678
678740769400429452474496563625687741806851646
       Capital Lease Obligations Min Short Term Debt
668
599
973
913
867
807
744
683
634
577
520
460
1,020
1,006
966
9661,0061,020460520577634683744807867913973599668
> Total Stockholder Equity
15,785
11,703
8,925
9,629
6,272
7,317
5,544
3,864
6,479
6,361
24,234
22,120
19,087
16,666
13,933
13,93316,66619,08722,12024,2346,3616,4793,8645,5447,3176,2729,6298,92511,70315,785
   Common Stock000000000000000
   Retained Earnings Total Equity000000000000000
   Accumulated Other Comprehensive Income 000000000000000
   Capital Surplus 000000000000000
   Treasury Stock000000000000000
   Other Stockholders Equity 000000000000000



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue6,203
Cost of Revenue-136
Gross Profit6,0676,067
 
Operating Income (+$)
Gross Profit6,067
Operating Expense-10,365
Operating Income-4,162-4,298
 
Operating Expense (+$)
Research Development3,111
Selling General Administrative4,437
Selling And Marketing Expenses-
Operating Expense10,3657,548
 
Net Interest Income (+$)
Interest Income12
Interest Expense-52
Net Interest Income-56-40
 
Pretax Income (+$)
Operating Income-4,162
Net Interest Income-56
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-2,410-4,162
EBIT - interestExpense = -52
-2,428
-2,376
Interest Expense52
Earnings Before Interest and Taxes (ebit)--2,358
Earnings Before Interest and Taxes (ebitda)-1,939
 
After tax Income (+$)
Income Before Tax-2,410
Tax Provision-18
Net Income From Continuing Ops-2,428-2,428
Net Income-2,428
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-56
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
ZENSARTECH.NSE
30 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ZENSARTECH.NSE.

ZENSARTECH.NSE Daily Candlestick Chart
MBECL.NSE
32 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MBECL.NSE.

MBECL.NSE Daily Candlestick Chart
HDFCMFGETF.NSE
35 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of HDFCMFGETF.NSE.

HDFCMFGETF.NSE Daily Candlestick Chart
GOLDSHARE.NSE
35 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of GOLDSHARE.NSE.

GOLDSHARE.NSE Daily Candlestick Chart
GOACARBON.NSE
35 minutes ago

I found you a RSI Bearish Reversal Divergence on the daily chart of GOACARBON.NSE.

GOACARBON.NSE Daily Candlestick Chart
BCOMSITR.INDX
38 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of BCOMSITR.INDX.

BCOMSITR.INDX Daily Candlestick Chart
BCOMSI.INDX
38 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of BCOMSI.INDX.

BCOMSI.INDX Daily Candlestick Chart
BCOMPR.INDX
38 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of BCOMPR.INDX.

BCOMPR.INDX Daily Candlestick Chart
VXN.INDX
40 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VXN.INDX.

VXN.INDX Daily Candlestick Chart
VX.INDX
40 minutes ago

I found you a Death Cross on the daily chart of VX.INDX.

VX.INDX Daily Candlestick Chart
RVX.INDX
41 minutes ago

I found you a Death Cross on the daily chart of RVX.INDX.

RVX.INDX Daily Candlestick Chart
NBI.INDX
41 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of NBI.INDX.

NBI.INDX Daily Candlestick Chart
DJUSST.INDX
42 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of DJUSST.INDX.

DJUSST.INDX Daily Candlestick Chart
CACTN.INDX
43 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CACTN.INDX.

CACTN.INDX Daily Candlestick Chart
CACTR.INDX
43 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CACTR.INDX.

CACTR.INDX Daily Candlestick Chart
BSPT.INDX
43 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of BSPT.INDX.

BSPT.INDX Daily Candlestick Chart
VBL.BSE
44 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VBL.BSE.

VBL.BSE Daily Candlestick Chart
LOYAL.BSE
48 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of LOYAL.BSE.

LOYAL.BSE Daily Candlestick Chart
TWL.BSE
48 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TWL.BSE.

TWL.BSE Daily Candlestick Chart
SSLFINANCE.BSE
51 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SSLFINANCE.BSE.

SSLFINANCE.BSE Daily Candlestick Chart
ESCORTSFIN.BSE
52 minutes ago

I found you a RSI Bullish Reversal Divergence on the daily chart of ESCORTSFIN.BSE.

ESCORTSFIN.BSE Daily Candlestick Chart
WAA.BSE
54 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of WAA.BSE.

WAA.BSE Daily Candlestick Chart
TRL.BSE
54 minutes ago

I found you a MACD Bearish Reversal Divergence on the daily chart of TRL.BSE.

TRL.BSE Daily Candlestick Chart
ANGEL.BSE
54 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of ANGEL.BSE.

ANGEL.BSE Daily Candlestick Chart
THEMISMED.BSE
56 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of THEMISMED.BSE.

THEMISMED.BSE Daily Candlestick Chart